COL7A1-transduced autologous epidermal stem cell sheets (Holostem Terapie Avanzate Srl)

N/A

Report date: 2024/07/30 17:49:27

Base Information

Drug NameCOL7A1-transduced autologous epidermal stem cell sheets (Holostem Terapie Avanzate Srl)
Drug Alias NameCOL7A1 encoding stem cell therapy (Holostem Terapie Avanzate Srl)ATMP (Holostem Terapie Avanzate Srl)Hologene-7 (Holostem Terapie Avanzate Srl)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Epidermal stem cell therapyCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector > γ-retroviral vectorCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionCollagen alpha-1(VII) chain modulatorsGene transference
TargetsCollagen alpha-1(VII) chain
Therapy Area/IndicationsEpidermolysis Bullosa, JunctionalEpidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHolostem Terapie Avanzate Srl
China Registration ClassN/A

Develop Information

Active CompaniesHolostem Terapie Avanzate Srl
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsEpidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica

Other Information

ATC CodeN/A
Related LinksN/A